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Spontaneous Tumors in SENCAR Mice
by Susan Melchionne,* Irving Seidman,t and
Benjamin L. Van Duuren*
A total of 305 female and 36 male SENCAR mice in six different groups were observed for 540 to 875
days for tumors as well as nonneoplastic lesions. Three ofthese groups were observed for their lifespans.
The 123 females and 36 males, observed for their lifespans (800 to 875 days) showed median survival times
ranging from 730 to 745 days. The average peak body weights were 42.4 g for females and 50.0 g for males.
In the animals observed for their lifespans, the total tumor incidence was 65.6% for females and 69.4%
for males. Both sexes showed a high incidence of papillary tumors of the lung, 16 to 39%o, which was
independent ofaging. Females showed a 5.1 to 21.0% incidence ofmammary tumors, which increased with
age. Males showed a high incidence of hyperplastic nodules of the liver, i.e., 12 of 36 animals. Other
frequently occurring tumors were leukemia and papillomas of the forestomach.
Introduction
In a companion report from this laboratory (1), we
described the use offemale SENCAR mice in the bioas-
say of chemicals for cocarcinogenic and tumor-promot-
ing activity and, in some instances, compared the skin
tumor responses in these animals with those observed
in our earlier work with female ICR/Ha mice (2).
During the course of the above work, and including
earlier trial experiments with SENCAR mice (3), we
have accumulated some background information on the
incidence ofspontaneous tumors (benignandmalignant)
and nonneoplastic lesions in SENCAR mice. In these
no-treatment control groups, 305 females and 36 males
were observed in six different experiments for periods
ranging from 540 to 875 days.
Because of the current interest in the use of these
mice forskin carcinogenesis assays, which wasthe main
topic ofthe conference at which the above paper (1) was
presented, it was considered useful to present our find-
ingsontheincidence ofspontaneouslesionsinSENCAR
mice.
The findings reported here were accumulated during
the course of mouse skin cocarcinogenesis research.
Hence, we do not have the detailed results that would
have been produced from a protocol designed for the
purpose of studying spontaneous tumors in SENCAR
mice.
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Table 1. Groups of mice observed for spontaneous lesions.
Number of mice
Group number
and sex
1 (female)a
2 (female)a
3 (female)'
4 (female)'
5 (male)b
6 (female)b
At
start
60
65
57
80
36
43
Necropsied
59
63
56
78
36
41
Median
survival
time, days
>540
>600
>605
745
750
730
Duration of
observation,
days
540
600
605
800
815
875
aMice were sacrificed at end ofexperiment. Mice were 4 to 7 weeks
old at the beginning of experiment and were sacrificed 540 to 605
days after the beginning of experiment (see last column). "Mice were kept to end of lifespan.
Methods
Allmicewere obtained fromOakRidge National Lab-
oratories (Oak Ridge, TN). They were used as no-treat-
ment control groups for concurrently running skin co-
carcinogenesis and two-stage experiments, some of
which have been reported earlier (1,3). The six groups
ofmice represent animals used over a period of7 years
in this laboratory. They were 4 to 7 weeks of age at
time ofarrivalinthelaboratory. Animals were allocated
randomly and numbered by toe-clipping during the
week ofarrival. After one week, they were assigned to
experimental groups as no-treatment controls. Mice
were housed, five per stainless steel cage, on heat-
treated hardwoodchipbedding. Malesandfemaleswere
housed in separate animal rooms, and males showing
aggressive behavior were separated and housed indi-
vidually. Rooms were maintained at 68 to 72°F and 50%
relative humidity. Fluorescent lighting used was on aMELCHIONNE, SEIDMAN, AND VAN DUUREN
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FIGURE 1. Survival curves for SENCAR mice groups 4 to 6.
12-hron-offcycle, and fresh air was supplied at the rate
of12to 15changesperhour. Theanimalshadfreeaccess
to Purina Rodent Chow (Number 5001) and tap water.
The six groups and relevant information are given in
Table 1.
Groups 1 to 3 were matched with skin application
groups and hence were killed at the termination ofthe
experiment. Groups 4 to 6 were kept to the end oftheir
lifespans.
Animals in moribund condition were killed. Necrop-
sies did not include the cranium, and routine sections
oftissues were not taken for groups 1 to 3. Only those
tissues which appeared abnormal by gross examination
were taken for histopathology. In groups 4 to 6, routine
sections of the following clinically normal tissues were
taken in addition to abnormal tissues: lung, liver, kid-
ney, stomach, spleen, and skin. Tissues were fixed in
formalinandstained withhematoxylinandeosin; special
stains were not used.
Results
Survival
Thesurvival curvesforgroups4, 5, and 6, whichwere
allowed to live out their lifespans, are shown in Figure
1. The median survival times forthese three groups are
shown in Table 1.
Body Weight
Body weights ofthe six groups ofanimals are shown
in Figure 2. The average peak body weight was 42.4 g
)0 600 700 800 900 950
for females, and peak body weight for the one group of
males was 50.0 g.
Tumors
Types of tumors observed are presented in Table 2,
along with the number and percentage of mice in each
group with each type of tumor. The mammary tumors
were defined byseveral criteria. Tumors were classified
as fibroadenomas ifproliferation ofboth the epithelium
and stroma was present and no necrosis was observed.
If necrosis was present, then the tumors were desig-
nated as adenocarcinomas. If the tumor could not be
classified as either a fibroadenoma or an adenocarci-
noma, the generic term mammary tumor was used.
These latter tumors are designated as unclassified tu-
mors in Table 2.
Nonneoplastic Lesions
Nonneoplastic lesions were seen in all six groups of
SENCAR mice examined and arelistedinTable3. With
the few exceptions noted below, these lesions were all
clinically apparent at necropsy and thus represent a
conservative number. In the males, group 5, cystic dil-
atation of the seminal vesicles was probably an age-
related lesion. The changes seen in the male skin and
some of the inflammatory changes seen in the kidneys
may have been attributable to amyloidosis. We did not
use special stains for amyloid, since nonneoplastic le-
sions were not of prime interest in our study.
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FIGURE 2. Average body weights of SENCAR mice groups 1 to 6.
Routine Sections
The numbers of routine sections of various organs
taken from groups 4 to 6, and the corresponding diag-
noses are shown in Table 4. The total number of clini-
cally normal sections from all tissues listed in Table 4
was 143. Of these, only 10, i.e., about 7%, were diag-
nosed as tumors or nonneoplastic lesions. Thus, these
routine sections did not markedly alter the overall tu-
mor and nonneoplastic lesions incidences shown in Ta-
bles 2 and 3.
Discussion
An examination ofthe tumor incidences in SENCAR
mice used in this laboratory, listed in Table 2, revealed
that five tumor types occur most frequently. These tu-
mor types and the frequency of their occurrence are
summarized in Table 5. These tumors occurred in one
or more of the six groups with a frequency of above
10%. With the exception of group 3, the overall tumor
inidences were greater than 50%. The most commonly
50.
40
30
20
1 0
0 -
60
50-
40
30
20 -
10-
0
SENCAR, Grou
ICR/Ha, 99 $
ip 6, 43$
SENCAR, Group 5, 36d'
0-
ICR/Ha, 60 0'
MST
20 40 60 80 100 120 140
AGE, WEEKS
FIGURE 3. Comparison of body weights and median survival times
(MST) between SENCAR and ICR/Ha mice.
occurring lung tumors were benign papillary tumors,
and the frequency of incidence ranged between 16 and
39% in the six groups. The incidence of lung tumors
does not appear to be age related, e.g., group 1, which
was observed for 540 days, had essentially the same
lung tumor incidence as that of groups 5 and 6, which
were observed for 815 and 875 days, respectively. In
another study (4), the most frequently observed tumors
were those of the lung in CD-1 mice of both sexes.
Male mice showed a high incidence of hyperplastic
nodules of the liver (group 5), 33.3%, as compared to
females, which showed a range of 0 to 2.4%. This dif-
ference between sexes has also been observed in
B6C3F1 hybrids and other mouse strains (5).
The mammary tumor incidences summarized in Table
5 showed a distinct increase with age, from 5.1% in
group 1 (540 days) to 22% in group 6 (875 days).
It was of interest to compare median survival times
and body weights of SENCAR mice from some of the
50 -
40 -
30 -
20.
10-
I
ck 50-
1- 40-
2 30-
Lu
3 20-
o 10-
(U
50
40
30
20
10'
137MELCHIONNE, SEIDMAN, AND VAN DUUREN
Site
Lung
Liver
Mammary gland
Forestomach
Glandular stomach
Duodenum
Kidney
Spleen
Skin
Uterus
Ovary
Adrenal gland
Bone
Blood vessel
Ear duct gland
Paraspinal cord
Tumor type
Papillary tumor
Papillary tumor
and secondary
carcinoma
Secondary
mammary
carcinoma
Hyperplastic
nodule
Hemangioma
Unclassified
Fibroadenoma
Carcinoma
Adenocarcinoma
Squamous cell
carcinoma
Papilloma
Undifferentiated
malignant tumor
Adenoma
Carcinoma
Hemangioma
Papilloma
Sarcoma
Leiomyoma
Sarcoma
Adenoma
Carcinoma
Brenner tumor
Hemangioma
Interstitial cell
tumor
Benign epithelial
tumor
Secondary
carcinoma
Sarcoma
Hemangioma
Squamous cell
carcinoma
Squamous cell
carcinoma
(undetermined
origin)
Table 2. Tumor incidences in SENCAR mice.
Number of mice with tumors (%)
Group 1 Group 2 Group 3 Group 4
19 18 9 20
(32.2) (28.6) (16.1) (25.6)
1
(1.3)
1
(1.7)
3
(5.1)
5
(8.5)
1
(1.6)
8
(12.7)
1
(1.6)
4
(6.3)
6
(10.7)
1
(1.8)
1
(1.8)
3
(5.4)
1
(1.3)
16
(20.5)
2
(2.6)
5
(6.4)
1
(1.3)
1
(1.8)
2
(3.6)
1
(1.8)
1
(1.6)
1
(1.6)
1
(1.6)
1
(1.3)
1
(1.3)
1
(1.3)
2
(2.6)
1
(1.3)
Group 5
12
(33.3)
12
(33.3)
4
(11.1)
6
(16.7)
1
(2.8)
Group 6
15
(39.0)
1
(2.4)
1
(2.4)
1
(2.4)
6
(14.6)
2
(4.9)
1
(2.4)
6
(14.6)
1
(2.4)
2
(4.9)
1
(2.4)
1
(2.8)
1
(2.8)
3
1
(2.4)
1
(2.4)
1
(2.4)
1
(2.4)
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Table 2. Continued.
Number ofmice with tumors (%)
Site Tumor type Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Prostate gland Adenoma 1
- - - - (2.8)
Multiple Leukemiaa 11 8 6 20 3 10
(18.6) (12.7) (10.7) (25.6) (8.3) (24.4)
Total number of mice 33 35 25 51 25 27
with tumors (55.9) (55.5) (44.6) (65.4) (69.4) (65.9)
aInclude lymphomas and leukemias at other sites.
Table 3. Nonneoplastic lesions in SENCAR mice.
Number of mice with lesions
Site Lesion type Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Skin Focal hyperplasia 1
Thymus
Trachea
Heart
Ear duct gland
Lung
Lymph node
Spleen
Liver
Kidney
Forestomach
Glandular stomach
Duodenum
Anus
Mammary gland
Uterus
Ovary
Prostate gland
Seminal vesicle
Testes
Chronic inflammation and hyperplasia
Chronic inflammation, ulcer
Chronic inflammation, fibrosis
Fibrous polyp
Hyperplasia
Necrosis
Chronic inflammation
Ulcer, granulation tissue
Chronic inflammation
Pneumonia
Chronic inflammation, fibrosis
Hyperplasia
Abscess
Hyperplasia
Focal necrosis
Chronic inflammation
Scar
Dilated tubules
Chronic inflammation with cystic
dilatation of tubules
Focal lymphocytic infiltrate
Hyperplasia of mucosa
Hyperkeratosis
Keratosis
Chronic inflammation
Glandular hyperplasia
Focal hyperplasia ofmucosa
Glandular hyperplasia and atypia
Hyperplastic polyp
Hyperplasia
Dilated acini
Dilated duct with squamous metaplasia
Endometrial polyp
Cystic hyperplasia
Fibrous polyp
Chronic inflammation with squamous
metaplasia
Squamous metaplasia of endometrium
Hemmorrhagic cyst
Acute inflammation, necrosis
Chronic inflammation, squamous
metaplasia and dilatation of ducts
Multiple fibrous-lined cysts
Cyst
Cystic dilatation
Atrophy and focal calcification
1
1
1
1
1
2
1
1
1
4
1
1
2
2
1
1
2
1
3
1
1
1
3
1
1
1
2
4
2
2
1
15
Total number oflesions
1
1
1
1
1
1
3
1
1
1
2
1
2
2
1
1
1
1
8
2
1
1
1
1 _
1 _
2 _
1 _
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Table 4. Pathology of clinically normal sections (groups 4-6).
Number of Number of
sections positive diagnoses
Group Group Group Group Group Group
Tissue 4 5 6 4 5 6
Lung 3 2 1 0 0 0
Liver 8 15 23 0 la 4d
Kidney 1 20 20 0 0 ld,2e
Stomach 0 20 12 - lb 0
Skin 4 7 5 0 lC 0
Spleen 2 0 0 0 - -
aHyperplastic nodule.
bPapilloma.
'Chronic inflammation and hyperplasia.
dLeukemia.
eFocal lymphocytic infiltrate.
control groups discussed here with ICR/Ha mice used
in most of our earlier studies on promoters, cocarcino-
gens, and whole carcinogens. Groups 5 and 6 from the
present report were compared with ICR/Ha mice of
both sexes used as control groups in an earlier study
(6). This comparison is illustrated in Figure 3. The
markedly higher weight and increased median survival
times of SENCAR mice compared to ICR/Ha mice of
both sexes are noteworthy.
In the course of the preparation of this report and
another one for the symposium (1), the differences in
results obtained in different laboratories with the same
strain of mice became obvious. The fact that these dif-
ferences are apparent stressed to us again the impor-
tance of standardizing laboratory animal care and han-
Table 5. Summary of frequently occurring tumors.
% Tumors
Group Group Group Group Group Group
Tumors 1 2 3 4 5 6
Total tumor- 55.9 55.5 44.6 65.4 69.4 65.9
bearing animals
Lung, papillary 32.2 28.6 16.1 25.6 33.3 39.0
tumors
Mammary tumors 5.1 14.3 14.3 24.4 0 22.0
Liver 1.7 1.8 0 0 33.3 2.4
hyperplastic
nodules
Leukemia 18.6 12.7 10.7 25.6 8.3 24.4
Forestomach 8.5 6.3 5.4 6.4 16.7 14.6
papillomas
Number of mice 59 63 56 78 36 41
necropsied
Duration of 540 600 605 800 815 875
observation
(days)
dling procedures. So many variables, often overlooked
and thought of as having minor relevance, are in fact
important forcomparingchronicanimalbioassayresults
among different laboratories. The importance of all
these variables has been discussed and reviewed (7).
From the papers presented atthis symposium, it was
clear that the SENCAR mouse will be valuable for
mouse skin tumorigenesis studies, particularly in two-
stage, i.e., initiation-promotion experiments. Inthis re-
gard, the utility of SENCAR mice for carcinogenesis
studies relating to tissues and organs other than skin
merits further attention. This point is important be-
cause in vitro models, while most valuable, must con-
tinue to be regarded as adjuncts to, rather than re-
placementsforinvivo animalbioassays. Thelatterview
is shared by other researchers in toxicology (8,9).
Our findings from the present work and from that
presented elsewhere inthis volume (1)indicate the need
for further work on the utility of the SENCAR mouse
in toxicology research.
Thisworkwas supported by EPA-CR-807317 and center grant CA-
13343. The opinions expressed in this document do not necessarily
reflect official U.S. Environmental Protection Agency policy. The
authors are indebted to Ms. K. Seymour for her contribution to the
histologic phase of this work.
This report is contribution no. 222 of the Laboratory of Organic
Chemistry and Carcinogenesis, Institute ofEnvironmental Medicine,
New York University Medical Center.
REFERENCES
1. Van Duuren, B. L., Melchionne, S., and Seidman, I. Phorbol myr-
istate acetate andcatechol asskin cocarcinogensinSENCAR mice.
Environ. Health Perspect. 68: 33-38 (1986).
2. Van Duuren, B. L., and Goldschmidt, B. M. Cocarcinogenic and
tumor-promoting agents intobacco carcinogenesis. J. Natl. Cancer
Inst. 56: 1237-1242 (1976).
3. Van Duuren, B. L., and Melchionne, S. Mouse skin application in
chemical carcinogenesis. In: Progress in Experimental Tumor Re-
search, Vol. 26 (F. Homburger, Ed.), Karger, Basel, 1983, pp.
154-168.
4. Sher, S. P., Jensen, R. D., and Bokelman, D. L. Spontaneous
tumors in control F344 and Charles River-CD rats and Charles
RiverCD-1 and B6C3F1 mice. Toxicol. Letters 11: 103-110 (1982).
5. Sher, S. P. Tumors in control hamsters, rats, and mice: Literature
tabulation. CRC Crit. Rev. Toxicol. 10: 49-79 (1982).
6. Van Duuren, B. L., Goldschmidt, B. M., Loewengart, G., Smith,
A. C., Melchionne, S., Seidman, I., and Roth, D. Carcinogenicity
ofhalogenated olefinic and aliphatic hydrocarbons in mice. J. Natl.
Cancer Inst. 63: 1433-1439 (1979).
7. Fox, J. G. Intercurrent disease and environmental variables in
rodent toxicology studies. In: Progress in Experimental Tumor
Research, Vol. 26 (F. Homburger, Ed.), Karger, Basel, 1983, pp.
208-240.
8. Zapp, J. A. Extrapolation ofanimalstudies tothehuman situation.
J. Toxicol. Environ. Health 2: 1425-1433 (1977).
9. Stark, D.M., andShopsis, C. Developingalternative assaysystems
for toxicity testing. Ann. N.Y. Acad. Sci. 406: 92-103 (1983).